Showing results (921-930 of 2,663) with videos related to

Sort By:
Pageof 267
Frontiers in Plant Science|November 12, 2015
Repeat-containing protein effectors of plant-associated organismsCarl H Mesarich, Joanna K Bowen, Cyril Hamiaux, et al.
AJR. American Journal of Roentgenology|October 6, 1997
Mediastinal mature teratoma: imaging featuresK H Moeller, M L Rosado-de-Christenson, P A Templeton
Molecules (Basel, Switzerland)|February 15, 2022
An Update of Nucleic Acids Aptamers Theranostic Integration with CRISPR/Cas TechnologyMina Roueinfar, Hayley N Templeton, Julietta A Sheng, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|February 1, 1985
A repeated dose pharmacokinetic study of a new hypnotic agent, zopiclone (Imovane)G W Houghton, M J Dennis, R Templeton, et al.
Australian and New Zealand Journal of Public Health|May 21, 2016
Enhanced surveillance of a lymphogranuloma venereum outbreak in Sydney 2010-2012David J Templeton, Kelly-Anne Ressler, Kirsty Hope, et al.
Journal of Nursing Scholarship : an Official Publication of Sigma Theta Tau International Honor Society of Nursing|June 20, 2018
Robotics in Nursing: A Bibliometric AnalysisHeather Carter-Templeton, Rachel M Frazier, Lin Wu, et al.
Human Reproduction (Oxford, England)|May 10, 2005
A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestationHaitham Hamoda, Premila W Ashok, Gillian M M Flett, et al.
The Journal of Family Planning and Reproductive Health Care|August 18, 2005
Home self-administration of misoprostol for medical abortion up to 56 days' gestationHaitham Hamoda, Premila W Ashok, Gillian M M Flett, et al.
American Journal of Lifestyle Medicine|January 20, 2026
MyFoodRx: Formative Research for the Development of an AI-Based Personalized Food-as-Medicine Smartphone ApplicationRita D DeBate, John Michael Templeton, Jay Hiteshkumar Jariwala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Deficiency of transporter for antigen presentation (TAP) in tumor cells allows evasion of immune surveillance and increases tumorigenesisA K Johnsen, D J Templeton, M Sy, et al.
Pageof 267